Prevention of Acute Kidney Injury.

Acute kidney injury (AKI) Cardiac surgery KDIGO bundles Prevention of acute kidney injury (AKI) Renal biomarkers

Journal

Critical care clinics
ISSN: 1557-8232
Titre abrégé: Crit Care Clin
Pays: United States
ID NLM: 8507720

Informations de publication

Date de publication:
Oct 2020
Historique:
entrez: 7 9 2020
pubmed: 8 9 2020
medline: 11 8 2021
Statut: ppublish

Résumé

Cardiac surgery-associated acute kidney injury (CSA-AKI) is a common complication after cardiac surgery and associated with a worse outcome. The pathogenesis of CSA-AKI is complex and multifactorial. Therapeutic options for severe CSA-AKI are limited to renal replacement therapy constituting a supportive measure. Therefore, risk identification, prevention, and early diagnosis are of utmost importance to improve patient outcomes. This review aims to provide an overview of the diagnosis, pathophysiologic mechanisms, and risk factors of CSA-AKI and delineates the strategies for AKI prevention available to improve patient outcomes after cardiac surgery.

Identifiants

pubmed: 32892822
pii: S0749-0704(20)30044-0
doi: 10.1016/j.ccc.2020.07.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-704

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure M. Küllmar and N-M. Wagner declare no conflicts of interest. A. Zarbock received fees from Astute Medical, BioMerieux, Braun, Baxter, Fresenius, AM Pharma, Amomed, AM Pharma, Ratiopharm, and Astellas and funding from Astute Medical, Astellas, Fresenius, Baxter, German Research Foundation, GIF, and BMBF. D. Engelman consults for Edwards Lifesciences.

Auteurs

Mira Küllmar (M)

Department of Anesthesiology, Intensive Care and Pain Medicine, University of Münster, Albert-Schweitzer-Campus 1, Building A1, Münster 48149, Germany.

Alexander Zarbock (A)

Department of Anesthesiology, Intensive Care and Pain Medicine, University of Münster, Albert-Schweitzer-Campus 1, Building A1, Münster 48149, Germany. Electronic address: zarbock@uni-muenster.de.

Daniel T Engelman (DT)

Heart and Vascular Program, Baystate Health and University of Massachusetts Medical School-Baystate, 759 Chestnut Street, Springfield, MA 01199, USA.

Subhasis Chatterjee (S)

Department of Surgery, Baylor College of Medicine, One Baylor Plaza, MS: BCM 390, Houston, TX 77030, USA; Division of Cardiovascular Surgery, Texas Heart Institute, Houston, TX, USA.

Nana-Maria Wagner (NM)

Department of Anesthesiology, Intensive Care and Pain Medicine, University of Münster, Albert-Schweitzer-Campus 1, Building A1, Münster 48149, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH